1.1100
+0.0100
+(0.91%)
At close: April 15 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 996,907 | 7 |
| Sales | 36,167 | 3 |
| Net Shares Purchased (Sold) | 960,740 | 10 |
| Total Insider Shares Held | 3.18M | -- |
| % Net Shares Purchased (Sold) | 43.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| NUSS JOHN M. PH.D. Officer | Sale at price 1.07 per share. | Direct | 2,019 | Apr 2, 2025 |
| MOHAN RAJU Chief Executive Officer | -- | Direct | -- | Mar 28, 2025 |
| NUSS JOHN M. PH.D. Officer | -- | Direct | -- | Mar 28, 2025 |
| NUSS JOHN M. PH.D. Officer | Sale at price 2.36 per share. | Direct | 49,841 | Dec 27, 2024 |
| GUJRATHI SHEILA Director | Purchase at price 2.31 per share. | Indirect | 300,573 | Dec 23, 2024 |
| NUSS JOHN M. PH.D. Officer | Sale at price 2.26 per share. | Direct | 29,682 | Dec 19, 2024 |
| MOHAN RAJU Chief Executive Officer | -- | Direct | -- | Dec 17, 2024 |
| NUSS JOHN M. PH.D. Officer | -- | Direct | -- | Dec 17, 2024 |
| NUSS JOHN M. PH.D. Officer | Conversion of Exercise of derivative security at price 0.20 per share. | Direct | 39,787 | Dec 10, 2024 |
| MOHAN RAJU Chief Executive Officer | Purchase at price 1.83 - 2.01 per share. | Direct | 959,889 | Nov 25, 2024 |
| MOHAN RAJU Chief Executive Officer | Conversion of Exercise of derivative security at price 0.20 per share. | Direct | 19,356 | Jun 10, 2024 |
| KRUEGER CHRISTOPHER W Officer | Sale at price 5.40 per share. | Direct | 8,921 | Apr 2, 2024 |
| AUSTER MARTIN Chief Financial Officer | Sale at price 5.40 per share. | Direct | 7,592 | Apr 2, 2024 |
| MOHAN RAJU Chief Executive Officer | Sale at price 5.40 per share. | Direct | 23,299 | Apr 2, 2024 |
| NUSS JOHN M. PH.D. Officer | Sale at price 5.40 per share. | Direct | 8,921 | Apr 2, 2024 |
| KRUEGER CHRISTOPHER W Officer | -- | Direct | -- | Mar 28, 2024 |
| AUSTER MARTIN Chief Financial Officer | -- | Direct | -- | Mar 28, 2024 |
| MOHAN RAJU Chief Executive Officer | -- | Direct | -- | Mar 28, 2024 |
| NUSS JOHN M. PH.D. Officer | -- | Direct | -- | Mar 28, 2024 |
| KRUEGER CHRISTOPHER W Officer | Sale at price 2.12 per share. | Direct | 11,210 | Dec 20, 2023 |
| MOHAN RAJU Chief Executive Officer | Sale at price 2.12 per share. | Direct | 124,660 | Dec 20, 2023 |
| NUSS JOHN M. PH.D. Officer | Sale at price 2.12 per share. | Direct | 37,334 | Dec 20, 2023 |
| KRUEGER CHRISTOPHER W Officer | -- | Direct | -- | Dec 15, 2023 |
| MOHAN RAJU Chief Executive Officer | -- | Direct | -- | Dec 15, 2023 |
| NUSS JOHN M. PH.D. Officer | -- | Direct | -- | Dec 15, 2023 |
| SUBRAMANIAM SOMU Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 30.03 per share. | Indirect | 1,475,858 | Oct 9, 2023 |
| NSV PARTNERS III LP Beneficial Owner of more than 10% of a Class of Security | Sale at price 30.03 per share. | Indirect | 1,475,858 | Oct 9, 2023 |
| MOHAN RAJU Chief Executive Officer | Sale at price 29.11 per share. | Direct | 873,231 | Oct 5, 2023 |
| MOHAN RAJU Chief Executive Officer | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 241,200 | Oct 5, 2023 |
| KRUEGER CHRISTOPHER W Officer | Sale at price 29.93 - 30.70 per share. | Direct | 449,699 | Oct 3, 2023 |
| KRUEGER CHRISTOPHER W Officer | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 120,600 | Oct 3, 2023 |
| NUSS JOHN M. PH.D. Officer | Sale at price 29.94 - 30.72 per share. | Direct | 299,933 | Oct 3, 2023 |
| NUSS JOHN M. PH.D. Officer | Conversion of Exercise of derivative security at price 0.20 - 8.04 per share. | Direct | 33,542 | Oct 3, 2023 |
| SUBRAMANIAM SOMU Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 37.81 per share. | Indirect | 2,142,634 | Sep 18, 2023 |
| NSV PARTNERS III LP Beneficial Owner of more than 10% of a Class of Security | Sale at price 37.81 per share. | Indirect | 2,142,634 | Sep 18, 2023 |
| KRUEGER CHRISTOPHER W Officer | Sale at price 32.25 - 33.97 per share. | Direct | 489,109 | Sep 5, 2023 |
| KRUEGER CHRISTOPHER W Officer | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 120,600 | Sep 5, 2023 |
| AUSTER MARTIN Chief Financial Officer | Sale at price 32.26 - 33.98 per share. | Direct | 863,334 | Sep 5, 2023 |
| MOHAN RAJU Chief Executive Officer | Sale at price 32.25 - 33.98 per share. | Direct | 978,343 | Sep 5, 2023 |
| MOHAN RAJU Chief Executive Officer | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 241,200 | Sep 5, 2023 |
| NUSS JOHN M. PH.D. Officer | Sale at price 32.24 - 33.41 per share. | Direct | 325,960 | Sep 5, 2023 |
| NUSS JOHN M. PH.D. Officer | Conversion of Exercise of derivative security at price 0.20 per share. | Direct | 2,000 | Sep 5, 2023 |
| SANDBORN WILLIAM J President | Sale at price 33.64 per share. | Direct | 400,354 | Aug 31, 2023 |
| SANDBORN WILLIAM J President | Conversion of Exercise of derivative security at price 14.85 per share. | Direct | 176,715 | Aug 31, 2023 |
| SANDBORN WILLIAM J President | Sale at price 32.69 - 33.12 per share. | Indirect | 114,810 | Aug 8, 2023 |
| MOHAN RAJU Chief Executive Officer | Sale at price 33.20 - 35.01 per share. | Direct | 1,005,570 | Aug 7, 2023 |
| MOHAN RAJU Chief Executive Officer | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 241,200 | Aug 7, 2023 |
| KRUEGER CHRISTOPHER W Officer | Sale at price 35.55 - 35.91 per share. | Direct | 533,797 | Aug 3, 2023 |
| KRUEGER CHRISTOPHER W Officer | Conversion of Exercise of derivative security at price 8.04 per share. | Direct | 120,600 | Aug 3, 2023 |
| NUSS JOHN M. PH.D. Officer | Sale at price 35.56 - 35.92 per share. | Direct | 355,986 | Aug 3, 2023 |
Related Tickers
EPIX ESSA Pharma Inc.
1.6300
-1.21%
HLVX HilleVax, Inc.
1.6500
-1.79%
RPTX Repare Therapeutics Inc.
1.1000
+18.51%
ASMB Assembly Biosciences, Inc.
9.81
-3.82%
SPRO Spero Therapeutics, Inc.
0.7444
+6.19%
IPSC Century Therapeutics, Inc.
0.5010
+0.36%
GLTO Galecto, Inc.
2.5700
+3.21%
CLRB Cellectar Biosciences, Inc.
0.2936
-0.31%
ANTX AN2 Therapeutics, Inc.
1.2600
-3.82%
TIL Instil Bio, Inc.
16.48
-1.90%